Replies to post #495771 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

The peer reviewed paper showed that the mutant type of SIGMAR 1 has a 25% reduction in the rate of decline.
That's enough drug effect for that group to be included in the labeling.

That was not a stat sig result. That is most likely due to the small n in that subgroup.